Brigitte Boisselier breaks 5-year silence, offers to ease cloning costs for Clonaid clients willing to go public
LAS VEGAS, Dec. 27 /PRNewswire-USNewswire/ -- Six years to the day after the birth of Baby Eve, the first cloned child, Dr. Brigitte Boisselier, head of the company that leads the Clonaid project, said Eve and other babies cloned by her company are growing up healthy and normal - and with no one invading their families' privacy.
"We've helped almost 100 families who were desperate to have a child," Boisselier said. "Our reward has been to see a number of cloned babies growing up normally, like any infant born through natural reproduction or through in vitro fertilization."
But she said the time has come to take things a step further.
"As of now, the Clonaid and Stemaid teams are ready to facilitate the cloning of one or more additional individuals at a reduced rate, provided they would agree - under contract - to go public after being cloned," Boisselier said. "We believe this is the right time to show publicly what we can do and offer the proof people wanted after the birth of Baby Eve."
She said many types of clients can benefit from her company's cloning technology.
"We can give hope to infertile and homosexual couples, to people who've lost a beloved family member and to single men and women who want a child created exclusively from their own genes," Boisselier said. "And we can also help those who suffer from ailments that can be cured with their own stem cells."
In addition, Boisselier announced the team's 500th clone blastocyst.
"Back in early 2002 when we had our first human clone blastocysts, we needed an average of 30 human eggs to get one good blastocyst," Boisselier explained. "Now, after seven years of practice, for every three eggs fused, we can repeatedly prepare one clone blastocyst. This is a m
Copyright©2008 PR Newswire.
All rights reserved